Core Viewpoint - Lumentum Holdings Inc. is expected to report significant growth in earnings and revenue for the fourth quarter, indicating a positive outlook for the company [1]. Financial Performance - Analysts predict Lumentum will report quarterly earnings of 81 cents per share, a substantial increase from 6 cents per share in the same quarter last year [1]. - The projected quarterly revenue is $469.92 million, compared to $308.3 million a year earlier, reflecting a strong year-over-year growth [1]. Company Developments - On August 7, Lumentum announced the expansion of its U.S.-based semiconductor facility, which may enhance its production capabilities and market position [2]. Stock Performance - Lumentum shares experienced a slight decline of 1.1%, closing at $115.03 on Monday [3]. Analyst Ratings - Morgan Stanley maintained an Equal-Weight rating and raised the price target from $85 to $92 [8]. - Susquehanna maintained a Positive rating and increased the price target from $95 to $125 [8]. - JP Morgan maintained an Overweight rating and boosted the price target from $100 to $123 [8]. - Wolfe Research initiated coverage with an Outperform rating [8]. - Rosenblatt maintained a Buy rating with a price target of $105 [8].

Core Viewpoint - Moderna is facing challenges due to declining COVID-19 vaccine sales and market uncertainty, leading to workforce reductions and expected financial losses in the upcoming earnings report [2]. Financial Performance - Analysts predict Moderna will report a quarterly loss of $2.97 per share, an improvement from a loss of $3.33 per share a year ago [1]. - Projected quarterly revenue is $112.96 million, down from $241 million a year earlier [1]. Workforce Reduction - Moderna announced plans to reduce its global workforce by approximately 10% by the end of the year [2]. Stock Performance - Following the announcement of workforce reductions, Moderna shares fell by 8.1%, closing at $29.56 [2]. Analyst Ratings - JP Morgan analyst Jessica Fye maintained an Underweight rating and reduced the price target from $33 to $26 [8]. - Evercore ISI Group analyst Cory Kasimov maintained an In-Line rating and cut the price target from $50 to $32 [8]. - Morgan Stanley analyst Matthew Harrison maintained an Equal-Weight rating and lowered the price target from $39 to $32 [8]. - Citigroup analyst Geoff Meacham initiated coverage with a Neutral rating and a price target of $40 [8]. - Argus Research analyst John Eade downgraded the stock from Buy to Hold [8].

Company Overview - LATAM Airlines is the leading airline in Latin America, headquartered in Santiago, Chile [11] - The company filed for Chapter 11 bankruptcy on May 26, 2020, and successfully emerged from bankruptcy on November 3, 2022, as part of a financial restructuring to reduce debt and adapt to challenges from the COVID-19 pandemic [11] - Post-bankruptcy, LATAM emerged with approximately $2.2 billion in liquidity and a 35% reduction in debt, alongside a more resilient operational structure [11] Investment Potential - LATAM Airlines holds a 2 (Buy) rating on the Zacks Rank, with a VGM Score of A, indicating strong investment potential [12] - The company is particularly appealing to growth investors, with a Growth Style Score of A, forecasting year-over-year earnings growth of 29.1% for the current fiscal year [12] - An analyst has revised their earnings estimate upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.05 to $4.17 per share [12] - LATAM has an average earnings surprise of +4%, further enhancing its attractiveness to investors [12] Conclusion - With a solid Zacks Rank and top-tier Growth and VGM Style Scores, LATAM Airlines is recommended for investors' consideration [13]

Group 1 - Etsy, Inc. is set to release its fourth-quarter earnings results on July 30, with analysts expecting earnings of 49 cents per share, an increase from 41 cents per share in the same period last year [1] - Projected quarterly revenue for Etsy is $647.63 million, slightly down from $647.81 million a year earlier [1] - On June 12, Etsy announced a $650 million offering of convertible senior notes [1] Group 2 - Etsy shares experienced a decline of 3.9%, closing at $60.30 [2] - Analysts have provided various ratings and price target adjustments for Etsy, with Stifel maintaining a Hold rating and raising the price target from $45 to $66 [4] - Canaccord Genuity maintained a Buy rating and increased the price target from $62 to $68, while Raymond James raised its Outperform rating target from $50 to $70 [4] - Deutsche Bank maintained a Hold rating with a price target increase from $40 to $47, and UBS raised its Neutral rating target from $45 to $62 [4]

Group 1 - Automatic Data Processing, Inc. (ADP) is expected to report fourth-quarter earnings of $2.23 per share, an increase from $2.09 per share in the same period last year [1] - The projected quarterly revenue for ADP is $5.05 billion, compared to $4.77 billion a year earlier [1] - In the third quarter, ADP reported revenues of $5.55 billion, surpassing the analyst consensus estimate of $5.49 billion [2] Group 2 - BMO Capital analyst Daniel Jester initiated coverage on ADP with a Market Perform rating and a price target of $340 [8] - Morgan Stanley analyst James Faucette maintained an Equal-Weight rating and raised the price target from $305 to $310 [8] - Mizuho analyst Dan Dolev maintained an Outperform rating and increased the price target from $321 to $332 [8] - RBC Capital analyst Ashish Sabadra reiterated a Sector Perform rating with a price target of $315 [8] - TD Securities analyst Bryan Bergin maintained a Hold rating and raised the price target from $298 to $321 [8]

Group 1 - Northrop Grumman Corporation is set to release its second-quarter earnings results on July 22, with expected earnings of $6.68 per share, an increase from $6.36 per share in the same period last year [1] - The company is projected to report quarterly revenue of $10.15 billion, slightly down from $10.22 billion a year earlier [1] - On May 29, Northrop Grumman issued $1 billion in new senior notes, divided into two tranches maturing in 2030 and 2035 [2] Group 2 - Northrop Grumman shares experienced a decline of 0.7%, closing at $515.29 [2] - Recent analyst ratings show a downgrade from Deutsche Bank from Buy to Hold, with a price target reduction from $580 to $542 [8] - Other analysts have maintained or adjusted their ratings and price targets, with Wells Fargo reducing its target from $547 to $525, RBC Capital from $575 to $550, and Truist Securities from $600 to $550 [8]

Group 1 - Zacks Premium offers various tools for investors to enhance their stock market confidence and investment strategies [1][2] - The Zacks Style Scores are complementary indicators that help investors select stocks likely to outperform the market in the next 30 days [3][4] Group 2 - The Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment characteristics [4][5][6][7] - The Zacks Rank is a proprietary stock-rating model that utilizes earnings estimate revisions to assist in portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.62% since 1988 [8][10] Group 3 - Enbridge Inc. is a leading energy infrastructure company with a vast pipeline system, transporting 3 million barrels of crude oil daily, accounting for nearly 63% of Canadian crude oil production to the U.S. [12] - Enbridge holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B and a Momentum Style Score of A, indicating potential for upward movement [13][14]

Earnings Report - Johnson & Johnson is set to release its second-quarter earnings results on July 16, with analysts expecting earnings of $2.68 per share, a decrease from $2.82 per share in the same period last year [1] - The company is projected to report quarterly revenue of $22.86 billion, an increase from $22.45 billion a year earlier [1] Drug Application - On July 8, Johnson & Johnson submitted a supplemental new drug application to the US FDA for CAPLYTA, aimed at preventing relapse in schizophrenia based on long-term safety and efficacy data [2] - Following the announcement, Johnson & Johnson shares rose by 0.9%, closing at $157.69 [2] Analyst Ratings - Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $169 to $171 [5] - Leerink Partners analyst David Risinger downgraded the stock from Outperform to Market Perform, reducing the price target from $169 to $153 [5] - Barclays analyst Matt Miksic maintained an Equal-Weight rating and cut the price target from $166 to $165 [5] - Raymond James analyst Jayson Bedford maintained an Outperform rating and increased the price target from $162 to $164 [5] - B of A Securities analyst Tim Anderson maintained a Neutral rating and reduced the price target from $171 to $159 [5]

Group 1 - Walgreens Boots Alliance, Inc. is set to release its third-quarter earnings results on June 26, with analysts expecting earnings of 34 cents per share, a decrease from 63 cents per share in the same period last year [1] - The company is projected to report quarterly revenue of $36.72 billion, slightly up from $36.35 billion a year earlier [1] - On April 21, Walgreens announced a $300 million settlement to resolve federal allegations regarding the filling of invalid prescriptions for opioids and other controlled substances [2] Group 2 - Deutsche Bank analyst downgraded Walgreens stock from Hold to Sell, reducing the price target from $11 to $9 [5] - Truist Securities maintained a Hold rating but lowered the price target from $13 to $12 [5] - UBS analyst maintained a Neutral rating and raised the price target from $9 to $10 [5] - Morgan Stanley maintained an Underweight rating and cut the price target from $9 to $7 [5]

Group 1 - Jabil Inc. is set to release its third-quarter earnings results on June 17, with analysts expecting earnings of $2.30 per share, an increase from $1.89 per share in the same period last year [1] - The company is projected to report quarterly revenue of $7.03 billion, compared to $6.76 billion a year earlier [1] - Jabil signed a memorandum of understanding with AVL Software and Functions GmbH, which is expected to enhance its capabilities in the e-drive and software sector [2] Group 2 - Goldman Sachs analyst Mark Delaney maintained a Buy rating and raised the price target from $165 to $188 [5] - Barclays analyst George Wang maintained an Overweight rating and increased the price target from $184 to $206 [5] - JP Morgan analyst Samik Chatterjee maintained an Overweight rating but reduced the price target from $175 to $154 [5] - UBS analyst David Vogt maintained a Neutral rating and raised the price target from $152 to $157 [5] - Stifel analyst Matthew Sheerin reiterated a Buy rating and increased the price target from $150 to $160 [5]